Immunophenotypes in “classical” B-cell chronic lymphocytic leukemia. Correlation with normal cellular counterpart and clinical findings

Luca Baldini(University of Milan), E. Polli(University of Milan), Rossella Calori(IRCCS Policlinico San Donato), Lilla Cro(University of Milan), Anna Teresa Maiolo(Policlinico San Matteo Fondazione), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Lucia Nobili

Cancer

October 15, 1990

10.1002/1097-0142(19901015)66:8<1738::aid-cncr2820660816>3.0.co;2-l

Cited by 23

Related Papers

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

|Blood|2003|490

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

|Blood|2009|433

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

|Journal of Clinical Oncology|2016|394

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

|Blood|2014|373

Angiogenesis in myelodysplastic syndromes

|British Journal of Cancer|1999|272